Added to YB: 2025-09-24
Pitch date: 2025-09-22
BWAY [bullish]
BrainsWay Ltd.
+5.59%
current return
Author Info
No bio for this author
Company Info
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally.
Market Cap
ILS 291.0M
Pitch Price
ILS 25.59
Price Target
34.10 (+26%)
Dividend
N/A
EV/EBITDA
57.60
P/E
69.45
EV/Sales
4.75
Sector
Health Care Equipment and Supplies
Category
growth
BrainsWay’s FDA Fast-Track and Valor-Backed Expansion
BWAY: Medical device co treating depression via TMS technology. 30% revenue growth by 2026, expanding margins to 20%+ (Rule of 50). Trading 14-15x 2026 EBITDA. New clinic-network model + accelerated FDA protocol = catalysts. 82% response vs 50-60% for competitors. Backed by Valor (11% stake). Bull case 120% return, bear case -35% loss.
Read full article (7 min)